Winn Way Internal Medicine Decatur, GA - 30030

Winn Way Internal Medicine is categorized under Operators of Nonresidential Buildings in Decatur, GA and active since 2009.

Winn Way Internal Medicine was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Operators of Nonresidential Buildings business, which does work in the B2B market, and is classified as a Operators of Nonresidential Buildings, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Curt Mann at the company’s single location by writing to 487 Winn Way # 202, Decatur, Georgia GA 30030 or by phoning (404) 294-0702. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Winn Way Internal Medicine
Contact Person: Curt Mann
Address: 487 Winn Way # 202, Decatur, Georgia 30030
Phone Number: (404) 294-0702
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Operators of Nonresidential Buildings
SIC Code: 6512
NAICS Code: 6211110
Share This Business:

Winn Way Internal Medicine was started in 2009 to provide professional Operators of Nonresidential Buildings under the SIC code 6512 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Curt Mann for inquiries that concern Winn Way Internal Medicine by calling the company number (404) 294-0702, as your correspondence is most welcome. Additionally, the physical location of the single location of Winn Way Internal Medicine can be found at the coordinates 33.78933,-84.27953 as well as the street address 487 Winn Way # 202 in Decatur, Georgia 30030.

For its online presence, you may visit Winn Way Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.